Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Neural Systems Underlying Individual Differences in Intertemporal Decision-making.

Elton A, Smith CT, Parrish MH, Boettiger CA.

J Cogn Neurosci. 2017 Mar;29(3):467-479. doi: 10.1162/jocn_a_01069. Epub 2016 Oct 25.

2.

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate.

Wolff N, Rubia K, Knopf H, Hölling H, Martini J, Ehrlich S, Roessner V.

Child Adolesc Psychiatry Ment Health. 2016 Jul 22;10:24. doi: 10.1186/s13034-016-0112-9. eCollection 2016.

3.

Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.

Weber SC, Beck-Schimmer B, Kajdi ME, Müller D, Tobler PN, Quednow BB.

Transl Psychiatry. 2016 Jul 5;6(7):e850. doi: 10.1038/tp.2016.113.

4.

The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans.

Courtney KE, Ghahremani DG, Ray LA.

Neuropsychopharmacology. 2016 Nov;41(12):2872-2881. doi: 10.1038/npp.2016.99. Epub 2016 Jun 17.

5.

Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.

Roche DJ, Ray LA, Yardley MM, King AC.

Curr Addict Rep. 2016 Mar;3(1):125-137. Epub 2016 Feb 3.

6.

Intertemporal Choice Behavior in Emerging Adults and Adults: Effects of Age Interact with Alcohol Use and Family History Status.

Smith CT, Steel EA, Parrish MH, Kelm MK, Boettiger CA.

Front Hum Neurosci. 2015 Nov 23;9:627. doi: 10.3389/fnhum.2015.00627. eCollection 2015.

7.

Preliminary functional MRI results from a combined stop-signal alcohol-cue task.

Karoly HC, Weiland BJ, Sabbineni A, Hutchison KE.

J Stud Alcohol Drugs. 2014 Jul;75(4):664-73.

8.

Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.

Mitchell JM, O'Neil JP, Jagust WJ, Fields HL.

Clin Transl Sci. 2013 Oct;6(5):400-3. doi: 10.1111/cts.12075. Epub 2013 Jun 13.

9.

Opioidergic and dopaminergic manipulation of gambling tendencies: a preliminary study in male recreational gamblers.

Porchet RI, Boekhoudt L, Studer B, Gandamaneni PK, Rani N, Binnamangala S, Müller U, Clark L.

Front Behav Neurosci. 2013 Oct 7;7:138. doi: 10.3389/fnbeh.2013.00138. eCollection 2013.

10.

Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.

Walker BM, Kissler JL.

Neuropsychopharmacology. 2013 Oct;38(11):2278-85. doi: 10.1038/npp.2013.129. Epub 2013 May 21.

11.

Dissociable brain signatures of choice conflict and immediate reward preferences in alcohol use disorders.

Amlung M, Sweet LH, Acker J, Brown CL, MacKillop J.

Addict Biol. 2014 Jul;19(4):743-53. doi: 10.1111/adb.12017. Epub 2012 Dec 12.

12.

Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system.

Sirohi S, Bakalkin G, Walker BM.

Front Mol Neurosci. 2012 Sep 27;5:95. doi: 10.3389/fnmol.2012.00095. eCollection 2012.

13.

Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Schacht JP, Anton RF, Voronin KE, Randall PK, Li X, Henderson S, Myrick H.

Neuropsychopharmacology. 2013 Feb;38(3):414-22. doi: 10.1038/npp.2012.195. Epub 2012 Oct 3.

14.

Targeting dynorphin/kappa opioid receptor systems to treat alcohol abuse and dependence.

Walker BM, Valdez GR, McLaughlin JP, Bakalkin G.

Alcohol. 2012 Jun;46(4):359-70. doi: 10.1016/j.alcohol.2011.10.006. Epub 2012 Mar 27. Review.

15.

The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF.

Alcohol Clin Exp Res. 2012 Mar;36(3):385-94. doi: 10.1111/j.1530-0277.2011.01633.x. Epub 2011 Sep 6. Review.

16.

Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal.

Ripley TL, Stephens DN.

Br J Pharmacol. 2011 Oct;164(4):1335-56. doi: 10.1111/j.1476-5381.2011.01406.x. Review.

17.

Recurrent, robust and scalable patterns underlie human approach and avoidance.

Kim BW, Kennedy DN, Lehár J, Lee MJ, Blood AJ, Lee S, Perlis RH, Smoller JW, Morris R, Fava M, Breiter HC; Phenotype Genotype Project in Addiction and Mood Disorders (PGP).

PLoS One. 2010 May 26;5(5):e10613. doi: 10.1371/journal.pone.0010613.

18.

Impulsivity, frontal lobes and risk for addiction.

Crews FT, Boettiger CA.

Pharmacol Biochem Behav. 2009 Sep;93(3):237-47. doi: 10.1016/j.pbb.2009.04.018. Epub 2009 May 3. Review.

Supplemental Content

Support Center